Tysabri Injection
Product Images NDC 64406-008

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tysabri (NDC 64406-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biogen Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Tys00 0058 01

Tys00 0058 01
A Kaplan-Meier curve chart comparing the proportion of patients with sustained increase in disability over time on therapy in weeks for TYSABRI (natalizumab) versus placebo. The chart shows lower proportion with sustained disability increase for TYSABRI (17%) compared to placebo (29%) at 120 weeks, with a p-value less than 0.001 indicating statistical significance.*
FDA Label Image

Tys00 0058 02

Tys00 0058 02
Label for TYSABRI (natalizumab) injection 300 mg/15 mL single-dose vial by Biogen Inc. The label includes storage instructions to refrigerate at 2-8°C (36-46°F) and warnings to protect from light and discard after opening. The product NDC is 64406-008-01, with additional manufacturer location details for Cambridge, MA, USA.*
FDA Label Image

Tys00 0058 03

Tys00 0058 03
Packaging label for TYSABRI (natalizumab) 300 mg/15 mL injection for intravenous infusion. The label specifies that the product must be diluted prior to use and is for prescription use only. It includes storage instructions to refrigerate at 2-8°C and warnings to not shake or freeze, and to protect from light. The label also contains manufacturer and distributor information for Biogen Inc., and lists inactive ingredients and note about no preservatives.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.